Literature DB >> 27196619

Binational Dengue Outbreak Along the United States-Mexico Border - Yuma County, Arizona, and Sonora, Mexico, 2014.

Jefferson M Jones, Benito Lopez, Laura Adams, Francisco Javier Navarro Gálvez, Alfredo Sánchez Núñez, Nubia Astrid Hernández Santillán, Lydia Plante, Ryan R Hemme, Mariana Casal, Elizabeth A Hunsperger, Jorge Muñoz-Jordan, Veronica Acevedo, Kacey Ernst, Mary Hayden, Steve Waterman, Diana Gomez, Tyler M Sharp, Kenneth K Komatsu.   

Abstract

Dengue is an acute febrile illness caused by any of four dengue virus types (DENV-1-4). DENVs are transmitted by mosquitos of the genus Aedes (1) and are endemic throughout the tropics (2). In 2010, an estimated 390 million DENV infections occurred worldwide (2). During 2007-2013, a total of three to 10 dengue cases were reported annually in Arizona and all were travel-associated. During September-December 2014, coincident with a dengue outbreak in Sonora, Mexico, 93 travel-associated dengue cases were reported in Arizona residents; 70 (75%) cases were among residents of Yuma County, which borders San Luis Río Colorado, Sonora, Mexico. San Luis Río Colorado reported its first case of locally acquired dengue in September 2014. To investigate the temporal relationship of the dengue outbreaks in Yuma County and San Luis Río Colorado and compare patient characteristics and signs and symptoms, passive surveillance data from both locations were analyzed. In addition, household-based cluster investigations were conducted near the residences of reported dengue cases in Yuma County to identify unreported cases and assess risk for local transmission. Surveillance data identified 52 locally acquired cases (21% hospitalized) in San Luis Río Colorado and 70 travel-associated cases (66% hospitalized) in Yuma County with illness onset during September-December 2014. Among 194 persons who participated in the cluster investigations in Yuma County, 152 (78%) traveled to Mexico at least monthly during the preceding 3 months. Four (2%) of 161 Yuma County residents who provided serum samples for diagnostic testing during cluster investigations had detectable DENV immunoglobulin M (IgM); one reported a recent febrile illness, and all four had traveled to Mexico during the preceding 3 months. Entomologic assessments among 105 households revealed 24 water containers per 100 houses colonized by Ae. aegypti. Frequent travel to Mexico and Ae. aegypti colonization indicate risk for local transmission of DENV in Yuma County. Public health officials in Sonora and Arizona should continue to collaborate on dengue surveillance and educate the public regarding mosquito abatement and avoidance practices. Clinicians evaluating patients from the U.S.-Mexico border region should consider dengue in patients with acute febrile illness and report suspected cases to public health authorities.

Entities:  

Mesh:

Year:  2016        PMID: 27196619     DOI: 10.15585/mmwr.mm6519a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Authors:  Todd M Bell; Virginia Espina; Svetlana Senina; Caitlin Woodson; Ashwini Brahms; Brian Carey; Shih-Chao Lin; Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Claudius Mueller; Elizabeth A Chlipala; Faye Sharman; Cynthia de la Fuente; Lance Liotta; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2017-04-23       Impact factor: 5.970

2.  Surveillance for Flaviviruses Near the Mexico-U.S. Border: Co-circulation of Dengue Virus Serotypes 1, 2, and 3 and West Nile Virus in Tamaulipas, Northern Mexico, 2014-2016.

Authors:  S Viridiana Laredo-Tiscareño; Javier A Garza-Hernandez; Ma Isabel Salazar; Erick J De Luna-Santillana; Chandra S Tangudu; Rosa C Cetina-Trejo; Gloria L Doria-Cobos; Santos Daniel Carmona-Aguirre; Julian E Garcia-Rejon; Carlos Machain-Williams; Bradley J Blitvich; Mario Alberto Rodríguez Pérez
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

3.  Socioeconomic and Human Behavioral Factors Associated With Aedes aegypti (Diptera: Culicidae) Immature Habitat in Tucson, AZ.

Authors:  Kathleen R Walker; Daniel Williamson; Yves Carrière; Pablo A Reyes-Castro; Steven Haenchen; Mary H Hayden; Eileen Jeffrey Gutierrez; Kacey C Ernst
Journal:  J Med Entomol       Date:  2018-06-28       Impact factor: 2.278

4.  Knowledge of Sexual Transmission of Zika Virus Among Women Who Are Pregnant or Intend to Become Pregnant, Arizona, 2017.

Authors:  Elizabeth J Anderson; Kacey Ernst; David O Garcia; Elise Lopez; Kristen Pogreba Brown; Erika Austhof; Dametreea Carr McCuin; Mary H Hayden; Mary P Koss
Journal:  Public Health Rep       Date:  2021-04-02       Impact factor: 2.792

5.  Serosurvey for dengue virus infection among pregnant women in the West Nile virus enzootic community of El Paso Texas.

Authors:  Douglas M Watts; Cynthia M Rodriguez; Pedro M Palermo; Veronica Suarez; Susan J Wong; Jeanette Orbegozo; Alan P Dupuis; Laura D Kramer; Fernando J Gonzalez; Gilbert A Handel
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

6.  Household and climate factors influence Aedes aegypti presence in the arid city of Huaquillas, Ecuador.

Authors:  James L Martin; Catherine A Lippi; Anna M Stewart-Ibarra; Efraín Beltrán Ayala; Erin A Mordecai; Rachel Sippy; Froilán Heras Heras; Jason K Blackburn; Sadie J Ryan
Journal:  PLoS Negl Trop Dis       Date:  2021-11-16

7.  Reemergence of Dengue in Southern Texas, 2013.

Authors:  Dana L Thomas; Gilberto A Santiago; Roman Abeyta; Steven Hinojosa; Brenda Torres-Velasquez; Jessica K Adam; Nicole Evert; Elba Caraballo; Elizabeth Hunsperger; Jorge L Muñoz-Jordán; Brian Smith; Alison Banicki; Kay M Tomashek; Linda Gaul; Tyler M Sharp
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

Review 8.  A review of Dengvaxia®: development to deployment.

Authors:  Stephen J Thomas; In-Kyu Yoon
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.